Nicholas Andrew Van De Graff

Title: Innovations of Nicholas Andrew Van De Graff

Introduction

Nicholas Andrew Van De Graff is a notable inventor based in Prahran, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of 4 patents to his name, his work continues to impact the medical community.

Latest Patents

One of his latest patents is titled "Bicyclic pyrimidinones and uses thereof." This invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt, or prodrug thereof. It also includes a method for the treatment or prophylaxis of a viral infection in a subject, which involves administering an effective amount of the compound. Additionally, a pharmaceutical composition or medicament comprising this compound is also provided. Another significant patent is "Compounds having antiviral properties," which similarly offers a compound of formula (I) or a pharmaceutically acceptable derivative, salt, or prodrug thereof. This invention also outlines a method for treating or preventing viral infections, along with pharmaceutical compositions that include the compound.

Career Highlights

Nicholas is currently associated with Avexa Limited, a company focused on developing innovative therapies. His work at Avexa Limited has allowed him to explore and expand his research in antiviral treatments, contributing to advancements in the pharmaceutical industry.

Collaborations

He has collaborated with notable coworkers such as Eric Dale Jones and David Ian Rhodes, enhancing the scope and impact of his research.

Conclusion

Nicholas Andrew Van De Graff's contributions to antiviral research and his innovative patents highlight his role as a significant inventor in the pharmaceutical field. His work continues to pave the way for new treatments and therapies.